Literature DB >> 25639470

An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation.

Peiying Ye1, Yu Liu2, Chong Chen2, Fei Tang1, Qi Wu3, Xiang Wang1, Chang-Gong Liu4, Xiuping Liu4, Runhua Liu5, Yang Liu6, Pan Zheng7.   

Abstract

mTOR senses nutrient and energy status to regulate cell survival and metabolism in response to environmental changes. Surprisingly, targeted mutation of Tsc1, a negative regulator of mTORC1, caused a broad reduction in miRNAs due to Drosha degradation. Conversely, targeted mutation of Raptor, an essential component of mTORC1, increased miRNA biogenesis. mTOR activation increased expression of Mdm2, which is hereby identified as the necessary and sufficient ubiquitin E3 ligase for Drosha. Drosha was induced by nutrient and energy deprivation and conferred resistance to glucose deprivation. Using a high-throughput screen of a miRNA library, we identified four miRNAs that were necessary and sufficient to protect cells against glucose-deprivation-induced apoptosis. These miRNA was regulated by glucose through the mTORC1-MDM2-DROSHA axis. Taken together, our data reveal an mTOR-Mdm2-Drosha pathway in mammalian cells that broadly regulates miRNA biogenesis as a response to alteration in cellular environment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25639470      PMCID: PMC4511160          DOI: 10.1016/j.molcel.2014.12.034

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  60 in total

1.  Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration.

Authors:  Pazit Polak; Nadine Cybulski; Jerome N Feige; Johan Auwerx; Markus A Rüegg; Michael N Hall
Journal:  Cell Metab       Date:  2008-11       Impact factor: 27.287

2.  Inducible gene targeting in mice.

Authors:  R Kühn; F Schwenk; M Aguet; K Rajewsky
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

3.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

4.  Met acts on Mdm2 via mTOR to signal cell survival during development.

Authors:  Anice Moumen; Salvatore Patané; Almudena Porras; Rosanna Dono; Flavio Maina
Journal:  Development       Date:  2007-02-28       Impact factor: 6.868

5.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.

Authors:  R Montes de Oca Luna; D S Wagner; G Lozano
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

6.  Dicer, Drosha, and outcomes in patients with ovarian cancer.

Authors:  William M Merritt; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Whitney A Spannuth; Rosemarie Schmandt; Diana Urbauer; Len A Pennacchio; Jan-Fang Cheng; Alpa M Nick; Michael T Deavers; Alexandra Mourad-Zeidan; Hua Wang; Peter Mueller; Marc E Lenburg; Joe W Gray; Samuel Mok; Michael J Birrer; Gabriel Lopez-Berestein; Robert L Coleman; Menashe Bar-Eli; Anil K Sood
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

Review 7.  Molecular mechanisms of mTOR-mediated translational control.

Authors:  Xiaoju Max Ma; John Blenis
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04-02       Impact factor: 94.444

Review 8.  Many roads to maturity: microRNA biogenesis pathways and their regulation.

Authors:  Julia Winter; Stephanie Jung; Sarina Keller; Richard I Gregory; Sven Diederichs
Journal:  Nat Cell Biol       Date:  2009-03       Impact factor: 28.824

9.  TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species.

Authors:  Chong Chen; Yu Liu; Runhua Liu; Tsuneo Ikenoue; Kun-Liang Guan; Yang Liu; Pan Zheng
Journal:  J Exp Med       Date:  2008-09-22       Impact factor: 14.307

10.  Regulation of TORC1 by Rag GTPases in nutrient response.

Authors:  Eunjung Kim; Pankuri Goraksha-Hicks; Li Li; Thomas P Neufeld; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

View more
  44 in total

1.  Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ).

Authors:  Heng-Jia Liu; Hilaire C Lam; Christian V Baglini; Julie Nijmeh; Alischer A Cottrill; Stephen Y Chan; Elizabeth P Henske
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

Review 2.  Trans-acting regulators of ribonuclease activity.

Authors:  Jaejin Lee; Minho Lee; Kangseok Lee
Journal:  J Microbiol       Date:  2021-02-10       Impact factor: 3.422

Review 3.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

4.  p53 dynamics in response to DNA damage vary across cell lines and are shaped by efficiency of DNA repair and activity of the kinase ATM.

Authors:  Jacob Stewart-Ornstein; Galit Lahav
Journal:  Sci Signal       Date:  2017-04-25       Impact factor: 8.192

5.  Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line.

Authors:  Katie Podshivalova; Eileen A Wang; Traver Hart; Daniel R Salomon
Journal:  Leuk Res       Date:  2018-09-22       Impact factor: 3.156

6.  A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice.

Authors:  Fei Tang; Peng Zhang; Peiying Ye; Christopher A Lazarski; Qi Wu; Ingrid L Bergin; Timothy P Bender; Michael N Hall; Ya Cui; Liguo Zhang; Taijiao Jiang; Yang Liu; Pan Zheng
Journal:  Elife       Date:  2017-12-05       Impact factor: 8.140

7.  Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition.

Authors:  Jo Ishizawa; Kenji Nakamaru; Takahiko Seki; Koichi Tazaki; Kensuke Kojima; Dhruv Chachad; Ran Zhao; Lauren Heese; Wencai Ma; Man Chun John Ma; Courtney DiNardo; Sherry Pierce; Keyur P Patel; Archie Tse; R Eric Davis; Arvind Rao; Michael Andreeff
Journal:  Cancer Res       Date:  2018-02-28       Impact factor: 12.701

Review 8.  Metabolic choreography of gene expression: nutrient transactions with the epigenome.

Authors:  Babukrishna Maniyadath; U S Sandra; Ullas Kolthur-Seetharam
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

9.  Aberrant mTORC1 activation kills tubular cells by inactivating miR148b-3p.

Authors:  Ken Inoki
Journal:  Kidney Int       Date:  2016-12       Impact factor: 10.612

Review 10.  Cancer's Fuel Choice: New Flavors for a Picky Eater.

Authors:  Gina M DeNicola; Lewis C Cantley
Journal:  Mol Cell       Date:  2015-11-19       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.